logo

For the Inventor, By the Inventor

Wilmette, IL, United States of America

Huan-Qiu Li

This inventor holds 7 USPTO granted patents and 6 published patent applications and 5 EPO patents. Top assignees: Abbvie Inc., Abbvie Deutschland Gmbh and Co Kg. Active years: 2016-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huan-Qiu Li. Retrieved from https://idiyas.com/inventor/huan-qiu-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 14.3

 

Average Co-Inventor Count = 10.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • North Chicago, IL (US) (2017)
  • Wilmette, IL (US) (2016 - 2018)

Company Filing History:

goldMedal7 out of 826 
 
Abbvie Inc.
 patents
silverMedal6 out of 167 
 
Abbvie Deutschland Gmbh and Co Kg
 patents
where one patent can have more than one assignee

Years Active: 2016-2018

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 9957274 - Indane inhibitors of EED and methods of their use (2018-05-01),
2. 9656955 - Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy (2017-05-23),
3. 9650334 - Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy (2017-05-16),
4. 9586945 - Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy (2017-03-07),
5. 9586942 - Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy (2017-03-07),
6. 9550754 - 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy (2017-01-24),
7. 9365512 - Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy (2016-06-14),

Title: Innovations and Contributions of Huan-Qiu Li

Introduction

Huan-Qiu Li is a notable inventor based in Wilmette, Illinois, who has made significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, he has focused on developing innovative compounds and methods that address various medical conditions.

Latest Patents

Among his latest patents, Huan-Qiu Li has developed indane inhibitors of EED and methods of their use. These compounds, characterized by a specific structural formula, are designed to treat EED-related conditions, including cancer. Additionally, he has patented pyrrolidine derivatives, which are GlyT1 inhibitors, along with pharmaceutical compositions that utilize these derivatives for therapeutic purposes.

Career Highlights

Huan-Qiu Li has worked with prominent companies in the pharmaceutical industry, including AbbVie Inc. and AbbVie Deutschland GmbH & Co. KG. His work has contributed to advancements in drug development and therapeutic applications, showcasing his expertise in the field.

Collaborations

Huan-Qiu Li has collaborated with notable colleagues, including Ying Wang and Hongyu H. Zhao, further enhancing the impact of his research and innovations.

Conclusion

Huan-Qiu Li's contributions to pharmaceutical innovations and his extensive patent portfolio highlight his role as a significant inventor in the industry. His work continues to influence the development of new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…